Table 1.
Patient characteristics
| Characteristic | No. of patients (%) |
| Total no. of patients | 13 (100) |
| Age (years) | |
| Median (range) | 53 (18–65) |
| Sex (male) | 7 (54) |
| Histology | |
| PTCLu | 7 (54) |
| ENKL | 3 (23) |
| AILD | 2 (15) |
| ALK-negative ALCL | 1 (8) |
| Ann Arbor stage | |
| Stage III | 7 (54) |
| Stage IV | 6 (46) |
| Performance status | |
| 0–1 | 12 (92) |
| 2 | 1 (8) |
| Elevated LDH | 7 (54) |
| IPI | |
| Low–low-intermediate | 8 (62) |
| High-intermediate–high | 5 (38) |
| Bulky disease (≥10 cm) | 5 (38) |
| Bone marrow involvement | 1 (8) |
| B symptom (+) | 4 (31) |
PTCLu, peripheral T-cell lymphoma, unspecified; ENKL, extranasal NK/T-cell lymphoma; AILD, angioimmunoblastic lymphoproliferative disease; ALCL, anaplastic large-cell T-cell lymphomas; LDH, lactate dehydrogenase.